scholarly journals Risk of a second cutaneous primary melanoma and basal cell carcinoma in patients with a previous primary diagnosis of melanoma: true impact of dermoscopy follow-up in the identification of high-risk persons/ Značaj dermoskopskog praćenja u identifikaciji osoba s visokim rizikom od pojave drugog primarnog kutanog melanoma – prikaz slučaja

2010 ◽  
Vol 2 (4) ◽  
pp. 144-148
Author(s):  
Irdina Drljević ◽  
Faruk Alendar

Abstract In clinical practice, positive personal history is considered to be as an indication of increased melanoma risk. The thickness of melanoma (Breslow Index) is the most important independent predicting factor of survival for stage I patients. We present a case of a second primary melanoma and basal cell carcinoma in a 48-year-old female patient with personal history of a superficial spreading melanoma located at the dorsal trunk with Breslow’s thickness of 0,5 mm and Clark’s II (stage IA) excised a year before, and a family background of melanoma. We would like to emphasize the benefits of digital dermatoscopy as well as teledermoscopy, and new teledermatology web services, in the follow-up of high-risk patients.

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Ali Ebrahimi ◽  
Mansour Rezaei ◽  
Reza Kavoussi ◽  
Mojtaba Eidizadeh ◽  
Seyed Hamid Madani ◽  
...  

Background. Periorbital basal cell carcinoma (BCC) is considered a high risk case because it is associated with high rate of recurrence and complication. Superpulsed CO2laser with intraoperative pathologic assessment could be an alternative and appropriate treatment for periocular lesions where Mohs micrographic surgery is not available.Objective. To evaluate the efficacy of superpulsed CO2laser therapy with intraoperative pathologic assessment on periocular BCC involving eyelash line.Method. This follow-up study was performed on 20 patients with a total of 21 BCC lesions that were pathologically documented. Firstly, debulkation of tumoral mass was done by curettage. Then, irradiation and intraoperative pathologic evaluation were done by concurrent CO2laser. The patients were followed up for a period of 36 months.Results. Out of 21 lesions, the nodular type accounted for 15 (71.4%) lesions, and 12 (57.1%) lesions were seen in the lower lid as the most common clinical type and site involvement. Twenty BCC lesions (95.2%) were treated after one session. Damage to eyelash was seen in 2 (10%) patients, but ectropion and other complications were not seen in any patient.Conclusion. Treatment with superpulsed CO2laser and intraoperative pathologic evaluation for periorbital BCC lesions much close to conjunctiva could be an effective method with minimal complications without major danger of recurrence. This modality can be used with care in the inner canthus and high risk pathologic lesions.


2019 ◽  
Vol 139 (5) ◽  
pp. S47
Author(s):  
M. Beatson ◽  
A. Misitzis ◽  
S. Landow ◽  
H. Higgins ◽  
R. Lew ◽  
...  

2015 ◽  
Vol 19 (4) ◽  
pp. 407-411 ◽  
Author(s):  
Emilie Bourgeault ◽  
Jimmy Alain ◽  
Eric Gagné

Background: Cutaneous carcinosarcoma is a rare primary tumor of the skin, characterized by biphasic epithelial and mesenchymal differentiation. Objective: Due to the limited number of cases reported, there is no consensus regarding treatment and prognosis. Some authors suggest that cutaneous carcinosarcomas should be viewed as aggressive tumors, with ancillary imaging used to evaluate potential metastatic disease. Other reports demonstrate an indolent disease course, especially with epidermal-type cutaneous carcinosarcomas. Methods: We report a case of cutaneous carcinosarcoma, which we treated with electrodessication and curettage following a shave biopsy. The tumor had an epithelial component resembling a basal cell carcinoma and a fibrosarcomatous stroma. Results: At 1-year follow-up, our patient did not show evidence of recurrence or metastasis. Conclusions: Our case suggests that a cutaneous carcinosarcoma with an epithelial component composed of basal cell carcinoma can be regarded as a high-risk nonmelanoma skin cancer.


Author(s):  
Mohamed El‐Khalawany ◽  
Wael M. Saudi ◽  
Eman Ahmed ◽  
Alsadat Mosbeh ◽  
Ahmed Sameh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document